Prelude Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-15,100
| Closed | -$133K | – | 1619 |
|
|
2025
Q4 | $133K | Buy |
+15,100
| New | +$83.1K | 0.01% | 1144 |
|
|
2025
Q2 | – | Sell |
-24,708
| Closed | -$113K | – | 1400 |
|
|
2025
Q1 | $113K | Buy |
24,708
+9,496
| +62% | +$44.3K | 0.01% | 1024 |
|
|
2024
Q4 | $72.9K | Sell |
15,212
-2,491
| -14% | -$12K | 0.01% | 1129 |
|
|
2024
Q3 | $83K | Buy |
17,703
+100
| +0.6% | +$536 | 0.01% | 1174 |
|
|
2024
Q2 | $99.5K | Sell |
17,603
-21,297
| -55% | -$110K | 0.01% | 1099 |
|
|
2024
Q1 | $160K | Sell |
38,900
-1,200
| -3% | -$4.8K | 0.01% | 1151 |
|
|
2023
Q4 | $169K | Sell |
40,100
-1,956
| -5% | -$7.89K | 0.01% | 979 |
|
|
2023
Q3 | $182K | Buy |
42,056
+2,296
| +6% | +$12.8K | 0.02% | 924 |
|
|
2023
Q2 | $262K | Buy |
39,760
+11,726
| +42% | +$75.2K | 0.02% | 707 |
|
|
2023
Q1 | $190K | Buy |
28,034
+4,258
| +18% | +$29.9K | 0.01% | 874 |
|
|
2022
Q4 | $176K | Buy |
+23,776
| New | +$232K | 0.01% | 999 |
|
|
2020
Q4 | – | Sell |
-4,834
| Closed | -$47K | – | 2241 |
|
|
2020
Q3 | $47K | Sell |
4,834
-2,668
| -36% | -$28.5K | 0.01% | 1139 |
|
|
2020
Q2 | $86K | Buy |
7,502
+1,000
| +15% | +$11.3K | 0.01% | 1002 |
|
|
2020
Q1 | $67K | Buy |
6,502
+2,409
| +59% | +$29.9K | 0.02% | 692 |
|
|
2019
Q4 | $67K | Buy |
4,093
+3,553
| +658% | +$53.7K | 0.01% | 1246 |
|
|
2019
Q3 | $7K | Sell |
540
-406
| -43% | -$5.66K | ﹤0.01% | 1534 |
|
|
2019
Q2 | $13K | Sell |
946
-788
| -45% | -$12.5K | ﹤0.01% | 1349 |
|
|
2019
Q1 | $32K | Buy |
1,734
+44
| +3% | +$1K | ﹤0.01% | 1238 |
|
|
2018
Q4 | $44K | Buy |
1,690
+767
| +83% | +$18K | ﹤0.01% | 1140 |
|
|
2018
Q3 | $21K | Sell |
923
-2,151
| -70% | -$43.9K | ﹤0.01% | 1307 |
|
|
2018
Q2 | $59K | Sell |
3,074
-4,902
| -61% | -$82K | ﹤0.01% | 1081 |
|
|
2018
Q1 | $134K | Buy |
7,976
+7,026
| +740% | +$118K | 0.01% | 791 |
|
|
2017
Q4 | $14K | Sell |
950
-573
| -38% | -$8.5K | ﹤0.01% | 1177 |
|
|
2017
Q3 | $27K | Buy |
1,523
+193
| +15% | +$3.23K | ﹤0.01% | 1256 |
|
|
2017
Q2 | $22K | Buy |
+1,330
| New | +$19.2K | ﹤0.01% | 1236 |
|
|
2017
Q1 | – | Sell |
-2,800
| Closed | -$45K | – | 1824 |
|
|
2016
Q4 | $45K | Buy |
2,800
+1,000
| +56% | +$16.1K | 0.01% | 1074 |
|
|
2016
Q3 | $30K | Sell |
1,800
-1,546
| -46% | -$20.8K | ﹤0.01% | 1224 |
|
|
2016
Q2 | $37K | Buy |
3,346
+1,395
| +72% | +$13.5K | 0.01% | 1107 |
|
|
2016
Q1 | $16K | Buy |
1,951
+751
| +63% | +$6.16K | ﹤0.01% | 1136 |
|
|
2015
Q4 | $11K | Buy |
+1,200
| New | +$12K | ﹤0.01% | 1252 |
|
|
2015
Q3 | – | Sell |
-6,300
| Closed | -$80K | – | 1863 |
|
|
2015
Q2 | $80K | Buy |
6,300
+1,300
| +26% | +$14K | 0.01% | 971 |
|
|
2015
Q1 | $47K | Buy |
+5,000
| New | +$56.5K | 0.01% | 1315 |
|
|
2014
Q3 | – | Sell |
-10,403
| Closed | -$168K | – | 2188 |
|
|
2014
Q2 | $168K | Buy |
10,403
+8,503
| +448% | +$113K | 0.03% | 815 |
|
|
2014
Q1 | $31K | Sell |
1,900
-1,775
| -48% | -$25.2K | 0.01% | 1573 |
|
|
2013
Q4 | $46K | Buy |
+3,675
| New | +$36.9K | 0.01% | 1062 |
|
Other funds holding VNDA
ACM
VCM
